BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37370092)

  • 1. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
    Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
    J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of colorectal cancer progression by immune-related lnc-SOX9-4 via suppression of YBX1 poly-ubiquitination and degradation.
    Zhao Y; Yang S; Nie H; Zhang D; Wang T; Sun Q; Wang X; Sun Y
    Cell Signal; 2023 Nov; 111():110854. PubMed ID: 37611648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H3K27 acetylation activated long noncoding RNA RP11-162G10.5 promotes breast cancer progression via the YBX1/GLO1 axis.
    Xie N; Zhang R; Bi Z; Ren W; You K; Hu H; Xu Y; Yao H
    Cell Oncol (Dordr); 2023 Apr; 46(2):375-390. PubMed ID: 36576700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA RP11-757G1.5 sponges miR-139-5p and upregulates YAP1 thereby promoting the proliferation and liver, spleen metastasis of colorectal cancer.
    Zhu X; Bu F; Tan T; Luo Q; Zhu J; Lin K; Huang J; Luo C; Zhu Z
    J Exp Clin Cancer Res; 2020 Oct; 39(1):207. PubMed ID: 33023613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Novel Long Noncoding RNAs - RP11-296E3.2 and LEF1-AS1can - Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer.
    Shi Q; He Y; Zhang X; Li J; Cui G; Zhang X; Wang X
    Med Sci Monit; 2019 Sep; 25():7042-7051. PubMed ID: 31536481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Super-enhancer-associated long noncoding RNA RP11-569A11.1 inhibited cell progression and metastasis by regulating IFIT2 in colorectal cancer.
    Chen H; Zheng J; Yan L; Zhou X; Jiang P; Yan F
    J Clin Lab Anal; 2021 Jun; 35(6):e23780. PubMed ID: 33942366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
    Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
    Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA PRKCQ-AS1 promotes CRC cell proliferation and migration via modulating miR-1287-5p/YBX1 axis.
    Cui G; Zhao H; Li L
    J Cell Biochem; 2020 Oct; 121(10):4166-4175. PubMed ID: 32619070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma.
    Wang Y; Feng YC; Gan Y; Teng L; Wang L; La T; Wang P; Gu Y; Yan L; Li N; Zhang L; Wang L; Thorne RF; Zhang XD; Cao H; Shao FM
    J Exp Clin Cancer Res; 2022 Aug; 41(1):260. PubMed ID: 36028903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
    Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
    J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA HOXC-AS3 promotes non-small-cell lung cancer growth and metastasis through upregulation of YBX1.
    Su H; Fan G; Huang J; Qiu X
    Cell Death Dis; 2022 Apr; 13(4):307. PubMed ID: 35387975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
    Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6.
    Jiang L; Zhao XH; Mao YL; Wang JF; Zheng HJ; You QS
    J Exp Clin Cancer Res; 2019 Nov; 38(1):465. PubMed ID: 31718693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA RP11-59H7.3 promotes cell proliferation and invasion metastasis in colorectal cancer by miR-139-5p/NOTCH1 axis.
    Zhu X; Luo C; Bu F; Lin K; Zhu Z
    Aging (Albany NY); 2020 Jun; 12(12):11653-11666. PubMed ID: 32507766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RP11-51O6.1 sponges miR-206 to accelerate colorectal cancer carcinogenesis and metastasis through upregulating YAP1.
    Zhu X; Zhu J; Tan T; Bu F; Zhao J; Luo C; Luo H
    Carcinogenesis; 2021 Jul; 42(7):984-994. PubMed ID: 34038520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of LncRNA-RP11-317J10.2 promotes cell proliferation and invasion and predicts poor prognosis in colorectal cancer.
    Luo J; Xu LN; Zhang SJ; Jiang YG; Zhuo DX; Wu LH; Jiang X; Huang Y
    Scand J Gastroenterol; 2018 Jan; 53(1):38-45. PubMed ID: 29073791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non‑coding RNA SNHG20 promotes colorectal cancer cell proliferation, migration and invasion via miR‑495/STAT3 axis.
    Wang Y; Fu J; Yang L; Liang Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Wu Y; Yang X; Chen Z; Tian L; Jiang G; Chen F; Li J; An P; Lu L; Luo N; Du J; Shan H; Liu H; Wang H
    Mol Cancer; 2019 Apr; 18(1):87. PubMed ID: 30979372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway.
    Wang J; Zhou J; Jiang C; Zheng J; Namba H; Chi P; Asakawa T
    Mol Oncol; 2019 Nov; 13(11):2344-2360. PubMed ID: 31246342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.